AGM/EGM7 Sept 2026, 09:00 pm
Parmax Pharma Ltd: FY26 Annual Report & AGM Notice
AI Summary
Parmax Pharma Limited has released its Annual Report for the Financial Year 2025-26 and the Notice for its 32nd Annual General Meeting (AGM). The AGM is scheduled for September 29, 2026, to be held via Video Conference. Key agenda items include the adoption of audited standalone financial statements for FY26 and the re-appointment of Shri Umang Gosalia as Director. Additionally, Mr. Dhiren Chandulal Shah is proposed for appointment as a Non-Executive Director and Chairman. The report also details corporate information, board composition, and auditor details.
Key Highlights
- Annual Report for FY 2025-26 released.
- 32nd AGM scheduled for September 29, 2026, via VC/OVAM.
- Adoption of FY26 audited financial statements is a key agenda item.
- Re-appointment of Director Umang Gosalia proposed.
- Appointment of Dhiren Chandulal Shah as Non-Executive Director and Chairman.
Price Impact
More from PARMAX